DEEPAK SABHARWAL; IANA MALASEVSKAIA. Role of PCSK9 Inhibitors in Contemporary Lipid-Lowering Era: A Systematic Review of LDL-C Reduction, Cardiovascular Outcomes, and Use in Statin-Intolerant and Very-High-Risk Patients. Journal For International Medical Graduates, [S. l.], v. 5, n. 1, 2026. DOI: 10.56570/hkdzy418. Disponível em: https://www.jimgs.com/ojs/index.php/journal/article/view/227. Acesso em: 3 apr. 2026.